ESR1 and breast carcinoma: Triple‐negative breast cancer (TNBC) is an aggressive subtype of breast cancer and is histochemically recognized by the negative expressions of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor‐2 (HER‐2).1